These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24657306)

  • 1. Inhibition of both focal adhesion kinase and fibroblast growth factor receptor 2 pathways induces anti-tumor and anti-angiogenic activities.
    Dao P; Jarray R; Smith N; Lepelletier Y; Le Coq J; Lietha D; Hadj-Slimane R; Herbeuval JP; Garbay C; Raynaud F; Chen H
    Cancer Lett; 2014 Jun; 348(1-2):88-99. PubMed ID: 24657306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
    Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
    Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
    Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
    Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of Yangzheng Xiaoji on angiogenesis and the role of the focal adhesion kinase pathway.
    Jiang WG; Ye L; Ji K; Frewer N; Ji J; Mason MD
    Int J Oncol; 2012 Nov; 41(5):1635-42. PubMed ID: 22971748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The noni anthraquinone damnacanthal is a multi-kinase inhibitor with potent anti-angiogenic effects.
    García-Vilas JA; Pino-Ángeles A; Martínez-Poveda B; Quesada AR; Medina MÁ
    Cancer Lett; 2017 Jan; 385():1-11. PubMed ID: 27816491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
    Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
    J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic properties of cafestol, a coffee diterpene, in human umbilical vein endothelial cells.
    Wang S; Yoon YC; Sung MJ; Hur HJ; Park JH
    Biochem Biophys Res Commun; 2012 May; 421(3):567-71. PubMed ID: 22525673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brucine, an indole alkaloid from Strychnos nux-vomica attenuates VEGF-induced angiogenesis via inhibiting VEGFR2 signaling pathway in vitro and in vivo.
    Saraswati S; Agrawal SS
    Cancer Lett; 2013 May; 332(1):83-93. PubMed ID: 23348691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IC-4, a new irreversible EGFR inhibitor, exhibits prominent anti-tumor and anti-angiogenesis activities.
    Li YB; Wang ZQ; Yan X; Chen MW; Bao JL; Wu GS; Ge ZM; Zhou DM; Wang YT; Li RT
    Cancer Lett; 2013 Oct; 340(1):88-96. PubMed ID: 23856030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular taurine induces angiogenesis by activating ERK-, Akt-, and FAK-dependent signal pathways.
    Baek YY; Cho DH; Choe J; Lee H; Jeoung D; Ha KS; Won MH; Kwon YG; Kim YM
    Eur J Pharmacol; 2012 Jan; 674(2-3):188-99. PubMed ID: 22130357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal adhesion kinase inhibitors are potent anti-angiogenic agents.
    Cabrita MA; Jones LM; Quizi JL; Sabourin LA; McKay BC; Addison CL
    Mol Oncol; 2011 Dec; 5(6):517-26. PubMed ID: 22075057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aqueous extract of the medicinal plant Patrinia villosa Juss. induces angiogenesis via activation of focal adhesion kinase.
    Jeon J; Lee J; Kim C; An Y; Choi C
    Microvasc Res; 2010 Dec; 80(3):303-9. PubMed ID: 20594998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anacardic acid (6-pentadecylsalicylic acid) inhibits tumor angiogenesis by targeting Src/FAK/Rho GTPases signaling pathway.
    Wu Y; He L; Zhang L; Chen J; Yi Z; Zhang J; Liu M; Pang X
    J Pharmacol Exp Ther; 2011 Nov; 339(2):403-11. PubMed ID: 21828260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
    Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F
    J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular disrupting activity of combretastatin analogues.
    Porcù E; Salvador A; Primac I; Mitola S; Ronca R; Ravelli C; Bortolozzi R; Vedaldi D; Romagnoli R; Basso G; Viola G
    Vascul Pharmacol; 2016 Aug; 83():78-89. PubMed ID: 27235861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
    Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T
    Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palladium (II) complex and thalidomide intercept angiogenic signaling via targeting FAK/Src and Erk/Akt/PLCγ dependent autophagy pathways in human umbilical vein endothelial cells.
    Aydinlik S; Uvez A; Kiyan HT; Gurel-Gurevin E; Yilmaz VT; Ulukaya E; Armutak EI
    Microvasc Res; 2021 Nov; 138():104229. PubMed ID: 34339726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo.
    Zhang S; Cao Z; Tian H; Shen G; Ma Y; Xie H; Liu Y; Zhao C; Deng S; Yang Y; Zheng R; Li W; Zhang N; Liu S; Wang W; Dai L; Shi S; Cheng L; Pan Y; Feng S; Zhao X; Deng H; Yang S; Wei Y
    Clin Cancer Res; 2011 Jul; 17(13):4439-50. PubMed ID: 21622720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
    Li X; Wang X; Ye H; Peng A; Chen L
    Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMND-309 promotes angiogenesis in human umbilical vein endothelial cells through activating erythropoietin receptor/STAT3/VEGF pathways.
    Du G; Zhu H; Yu P; Wang H; He J; Ye L; Fu F; Zhang J; Tian J
    Eur J Pharmacol; 2013 Jan; 700(1-3):173-80. PubMed ID: 23276662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.